Glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as a potent class of drugs in the management of type 2 diabetes mellitus. These agents simulate the actions of naturally occurring GLP-1, enhancing insulin secretion and reducing glucagon release. Recent research have yielded a extens

In the realm of peptide synthesis, achieving high yield and purity is paramount. A multitude of factors influence manufacturing processes, and optimizing these variables is crucial for success. Efficient purification techniques, coupled with meticulous synthesis conditions, are key to minimizing